Results for dose-optimization phase of PRIMO trial of duvelisib in patients with R/R PTCL Dec. 30, 2019
New BALB/c-hCD3E mouse model for evaluating the therapeutic efficacy of T-cell bispecific Abs Dec. 30, 2019
Baergic Bio enters agreements with AstraZeneca and Cincinnati Children's Hospital for AZD-7325 Dec. 27, 2019
Promising overall response and duration of response in phase IIa trial of PTX-200 in breast cancer Dec. 27, 2019
RSS